APPLICATION
ANDA212514
TYPE
ANDA
ORIGINAL APPROVAL
2021-12-14
LATEST ACTION
2021-12-14
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE, LIPOSOMAL
MARKETING STATUS
Prescription
Products
AMPHOTERICIN BPrescription
AMPHOTERICIN B 50MG/VIAL · INJECTABLE, LIPOSOMAL · INJECTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.